{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Rana Aldisi",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Effects of peptides derived from BACE1 catalytic domain on APP processing",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "PFAM": "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns",
      "RGD": "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"
    },
    "path": "app/yeon2007.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",
      "key": "fa26885d2d0778098efbe5689330cbbc",
      "line": 85,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 8,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Taken together, these results show that BI-1 and BI-3 not only selectively reduce the level of APPbeta but also lead to the accumulation of APPalpha in cells with no change of full-length APP level.",
      "key": "cf2c7886ac19e066932774d6b2ba4436",
      "line": 130,
      "relation": "decreases",
      "source": 8,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",
      "key": "509c0f47dba4697b14c0b778a4cf97c4",
      "line": 86,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 8,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Surprisingly, BI-1 treatment resulted in a drastic, dose-dependent increase in the level of intracellular APPa (Figs. 2A and 3A). BI-3 also induced the accumulation of intracellular APPa until the concentration of BI-3 was raised to 12.5 mM; however, treatment of BI-3 with 25 mM decreased the level of intracellular APPa.",
      "key": "17071b6a872d6af850ef88a434d756da",
      "line": 107,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 8,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Taken together, these results show that BI-1 and BI-3 not only selectively reduce the level of APPbeta but also lead to the accumulation of APPalpha in cells with no change of full-length APP level.",
      "key": "4df08fc22f594eb752a512c5f45d2610",
      "line": 132,
      "relation": "increases",
      "source": 8,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "66e69cc9578c33179068ea6fec70743a",
      "line": 115,
      "relation": "causesNoChange",
      "source": 8,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "912a738204ea79f850a8830f48538c11",
      "line": 120,
      "relation": "causesNoChange",
      "source": 8,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "These results suggest that BACE1 derived peptides do not directly inhibit BACE activities in vitro when the fluorogenic peptides are used as a substrate.",
      "key": "d66fe38fcf5311eb10fd2dcd2467f2f5",
      "line": 141,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 8,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment effectively reduced Ab 40 levels (IC50 = 0.06 mM) in the conditioned medium. BI-3 also inhibited Ab 40 production (IC50 = 0.2 mM), although the effective concentrations were relatively high compared to those of BI-1.",
      "key": "ab4b7ab40bb07be54ff0f4e234752998",
      "line": 149,
      "relation": "decreases",
      "source": 8,
      "target": 0
    },
    {
      "key": "5eacf42fe8f481a32310a472fcbfb0ce",
      "relation": "hasVariant",
      "source": 5,
      "target": 8
    },
    {
      "key": "8a69494cca72287ffe617df3976b12dc",
      "relation": "hasVariant",
      "source": 5,
      "target": 9
    },
    {
      "key": "a05d0e299e6906f2712ebe451ff5b8f7",
      "relation": "hasVariant",
      "source": 5,
      "target": 6
    },
    {
      "key": "43c1f7b4e36965a421928175b44ca62e",
      "relation": "hasVariant",
      "source": 5,
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",
      "key": "0ac3fdff1586fd591ba2af04d3664bda",
      "line": 87,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 9,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment dose-dependently inhibited the release of both sAPPa and sAPPb in the conditioned medium (Figs. 2A and 3A). The 50% inhibitory concentrations (IC50) of BI-1 were about 1.5 mM for sAPPa and 0.9 mM for APPb, respectively. But BI-2, which is mainly composed of the core region BACE1 69–73, did not show the inhibitory effects",
      "key": "06bfad8405121a3e1c11c08756de8d9f",
      "line": 88,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 9,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "f4b573c2453909acad531f503e281cb4",
      "line": 116,
      "relation": "causesNoChange",
      "source": 9,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "f6a1b61922ccf1021f7c30a5feaa7a0d",
      "line": 121,
      "relation": "causesNoChange",
      "source": 9,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",
      "key": "2f860c787228d23fc4ee9fdb9829fa44",
      "line": 95,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 6,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Taken together, these results show that BI-1 and BI-3 not only selectively reduce the level of APPbeta but also lead to the accumulation of APPalpha in cells with no change of full-length APP level.",
      "key": "efd131f40b4cf96b3523f591623e6b89",
      "line": 131,
      "relation": "decreases",
      "source": 6,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",
      "key": "9285abb8adcab9e078174dc2cb4a861a",
      "line": 96,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "decreases",
      "source": 6,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Surprisingly, BI-1 treatment resulted in a drastic, dose-dependent increase in the level of intracellular APPa (Figs. 2A and 3A). BI-3 also induced the accumulation of intracellular APPa until the concentration of BI-3 was raised to 12.5 mM; however, treatment of BI-3 with 25 mM decreased the level of intracellular APPa.",
      "key": "d03a164f03527997cdf1b5d00cbae4e6",
      "line": 108,
      "object": {
        "location": {
          "name": "intracellular",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 6,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Taken together, these results show that BI-1 and BI-3 not only selectively reduce the level of APPbeta but also lead to the accumulation of APPalpha in cells with no change of full-length APP level.",
      "key": "6cfbe413a6c1d8b5de045ee27a095285",
      "line": 133,
      "relation": "increases",
      "source": 6,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "07d9ce0e5211f931730e07d948d13855",
      "line": 117,
      "relation": "causesNoChange",
      "source": 6,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "01fc2c9ab7ff6ef84677ac74a4e3d8bc",
      "line": 122,
      "relation": "causesNoChange",
      "source": 6,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "These results suggest that BACE1 derived peptides do not directly inhibit BACE activities in vitro when the fluorogenic peptides are used as a substrate.",
      "key": "6c01c1383e9be2cb4e806640c7a5dd1f",
      "line": 140,
      "object": {
        "modifier": "Activity"
      },
      "relation": "causesNoChange",
      "source": 6,
      "target": 5
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-1 treatment effectively reduced Ab 40 levels (IC50 = 0.06 mM) in the conditioned medium. BI-3 also inhibited Ab 40 production (IC50 = 0.2 mM), although the effective concentrations were relatively high compared to those of BI-1.",
      "key": "ebb72ac7f09e24560fe629632cb10e66",
      "line": 150,
      "relation": "decreases",
      "source": 6,
      "target": 0
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",
      "key": "7e7d71d92c2f94b1cdeb07c419e0d089",
      "line": 97,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 7,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "BI-3 also potentially inhibited the release of sAPPb (IC50 = 0.5 mM) and sAPPa (IC50 = 3.4 mM, Figs. 2B and 3B). BI- 4, which is short peptide of BI-3, showed no effects on sAPP secretion.",
      "key": "11308eabf7f3243e516d7c2103342fa8",
      "line": 98,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "causesNoChange",
      "source": 7,
      "target": 2
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "904c46640a64bd47e75a6279fd7dfb11",
      "line": 118,
      "relation": "causesNoChange",
      "source": 7,
      "target": 1
    },
    {
      "citation": {
        "authors": [
          "Hwang EM",
          "Jeon YJ",
          "Kim TY",
          "Yeon SW"
        ],
        "date": "2007-04-01",
        "db": "PubMed",
        "db_id": "17293005",
        "db_name": "Effects of peptides derived from BACE1 catalytic domain on APP processing.",
        "first": "Yeon SW",
        "journal": "Peptides",
        "last": "Kim TY",
        "pages": "838-44",
        "volume": "28"
      },
      "evidence": "Neither, BI-1 nor, BI-3, nor any of the other peptides used in this study, induced any changes of full-length APP levels. They also did not affect the level of b-actin.",
      "key": "d0d8396b2fd2b8de5baa8271b7d8509f",
      "line": 123,
      "relation": "causesNoChange",
      "source": 7,
      "target": 4
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 40\")",
      "concept": {
        "name": "amyloid-beta polypeptide 40",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "9e0dfb730cc36c0afbaa05a340211fda"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "concept": {
        "name": "amyloid-beta",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "e9557ea6ec74113b73fe23f4bd76b524"
    },
    {
      "bel": "p(CONSO:\"sAPP-alpha\")",
      "concept": {
        "name": "sAPP-alpha",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "8846a5456d7a07582369bbaed50c87d7"
    },
    {
      "bel": "p(CONSO:\"sAPP-beta\")",
      "concept": {
        "name": "sAPP-beta",
        "namespace": "CONSO"
      },
      "function": "Protein",
      "id": "6b57d0f32e7301273a36c1e13f0d25d7"
    },
    {
      "bel": "p(HGNC:ACTB)",
      "concept": {
        "name": "ACTB",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3a08ba6ac28a45248228444f719951c5"
    },
    {
      "bel": "p(HGNC:BACE1)",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "334dd03e9a5f223f13995e497b1c156e"
    },
    {
      "bel": "p(HGNC:BACE1, frag(\"228_236\"))",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "60e6ed6b5b57b5a4e3846f8ea52080f8",
      "variants": [
        {
          "kind": "frag",
          "start": 228,
          "stop": 236
        }
      ]
    },
    {
      "bel": "p(HGNC:BACE1, frag(\"230_235\"))",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5d05199af40761f4d8edda05162d287e",
      "variants": [
        {
          "kind": "frag",
          "start": 230,
          "stop": 235
        }
      ]
    },
    {
      "bel": "p(HGNC:BACE1, frag(\"67_78\"))",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "054c744bc58707689f3ee20347d0e9a7",
      "variants": [
        {
          "kind": "frag",
          "start": 67,
          "stop": 78
        }
      ]
    },
    {
      "bel": "p(HGNC:BACE1, frag(\"69_75\"))",
      "concept": {
        "name": "BACE1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3a59a61c3138bf792e445a1283e266e8",
      "variants": [
        {
          "kind": "frag",
          "start": 69,
          "stop": 75
        }
      ]
    }
  ]
}